AHA Urges the CMS to Consider Alternative Payment Solutions for CAR T Therapy

AHA writes to urge the Centers for Medicare & Medicaid Services to consider alternative payment solutions for Chimeric Antigen Receptor T-cell (CAR T) therapy.

View full details in the following letter.